R
Robin M. Murray
Researcher at King's College London
Publications - 1583
Citations - 128883
Robin M. Murray is an academic researcher from King's College London. The author has contributed to research in topics: Psychosis & Schizophrenia. The author has an hindex of 171, co-authored 1539 publications receiving 116362 citations. Previous affiliations of Robin M. Murray include University of Cambridge & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Duration of untreated psychosis and pathway to care in Riyadh, Saudi Arabia.
TL;DR: This study aims to describe DUP and its association with both demographic factors and pathways to care in Riyadh, Saudi Arabia.
Journal ArticleDOI
A multimodal imaging study of recognition memory in very preterm born adults.
Chieh-En Jane Tseng,Sean Froudist-Walsh,Philip J. Brittain,Vyacheslav Karolis,Chiara Caldinelli,Jasmin Kroll,Serena J. Counsell,Steven Williams,Robin M. Murray,Chiara Nosarti +9 more
TL;DR: The results suggest that neuroanatomical alterations in very preterm born individuals may be underlying their poorer recognition memory performance, and structural and functional brain metrics showed statistically significant group differences.
Journal ArticleDOI
Incidence of first contact psychosis in Sao Paulo, Brazil
Paulo Rossi Menezes,Marcia Scazufca,K Casagrande,Ana Cristina Belizia Schlithler,D Cordeiro,Letícia Maria Silva Coutinho,Geraldo F. Busatto,Philip McGuire,Paul Fearon,Robin M. Murray +9 more
Journal ArticleDOI
Cognitive performance in presumed obligate carriers for psychosis
Timothea Toulopoulou,F. Mapua-Filbey,Seema N Quraishi,Eugenia Kravariti,Robin G. Morris,Colm McDonald,Muriel Walshe,Elvira Bramon,Robin M. Murray +8 more
TL;DR: The presumed obligate carriers showed impairments in verbal memory and in visuospatial manipulations, suggesting that these individuals transmit vulnerability for psychosis to their offspring in terms of a disability to recall verbal information and an impaired capacity to perceive spatial relations.
Journal ArticleDOI
The effect of clozapine on factors controlling glucose homeostasis.
TL;DR: Clozapine does not alter GH, IGF-1, or IGFBP-1 within 3 months of commencing treatment, indicating that alteration in glucose tolerance associated with clozAPine treatment involves other mechanisms yet to be elucidated.